1. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer

   • Chunyan Li
   • Lin Zhang
   • Junyao Li

   Review – Cancer Research 19 October 2019 Pages: 2875 - 2889

   

2. Correlations between microsatellite instability and the biological behaviour of tumours

   • Guang Yang
   • Ru-yi Zheng
   • Zai-shun Jin

   Review – Cancer Research Open access 15 October 2019 Pages: 2891 - 2899

   

3. Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion

   • Adhiraj Roy
   • Gopeshwar Narayan

   Review – Cancer Research 25 October 2019 Pages: 2901 - 2910

   

4. Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer

   • Ying Wang
   • Yanxia Liu
   • Tongmei Zhang

   Original Article – Cancer Research Open access 23 October 2019 Pages: 2911 - 2920

   

5. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma

   • Xiaolin Peng
   • Yao Liu
   • Dexin Kong

   Original Article – Cancer Research 16 October 2019 Pages: 2921 - 2936

   

6. Are shape morphologies associated with survival? A potential shape-based biomarker predicting survival in lung cancer

   • Maliazurina Saad
   • Ik Hyun Lee
   • Tae-Sun Choi

   Original Article – Cancer Research 16 October 2019 Pages: 2937 - 2950

   

7. Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo

   • Qianqian Jiang
   • Yue Yuan
   • Wen Zhu

   Original Article – Cancer Research 25 October 2019 Pages: 2951 - 2967

   

8. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome

   • Mithalesh Kumar Singh
   • Lata Singh
   • Seema Kashyap

   Original Article – Cancer Research 14 October 2019 Pages: 2969 - 2982

   

9. Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015–2018

   • Lidija Stevanovic
   • Matthias Choschzick
   • Zsuzsanna Varga

   Original Article – Cancer Research Open access 18 October 2019 Pages: 2983 - 2994

   

10. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis

    • Xialing Huang
    • Liling Long
    • Xiangfei Chai

    Original Article – Cancer Research Open access 29 October 2019 Pages: 2995 - 3003

    

11. Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

    • Yamei Zhao
    • Xiaoxu Ge
    • Lifeng Sun

    Review – Clinical Oncology 24 October 2019 Pages: 3005 - 3019

    

12. Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors

    • Ning Zhu
    • Shanshan Weng
    • Ying Yuan

    Review – Clinical Oncology 15 October 2019 Pages: 3021 - 3036

    

13. A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis

    • Josias Bastian Grogg
    • Kym Schneider
    • Christian Daniel Fankhauser

    Review – Clinical Oncology 23 October 2019 Pages: 3037 - 3045

    

14. Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding?

    • Christian Tanislav
    • Charles Christian Adarkwah
    • Karel Kostev

    Original Article – Clinical Oncology 10 September 2019 Pages: 3047 - 3054

    

15. PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy

    • Zhenlin Yang
    • Jiachen Xu
    • Jie He

    Original Article – Clinical Oncology 14 September 2019 Pages: 3055 - 3065

    

16. Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas

    • Frank Kroschinsky
    • Denise Röllig
    • Mathias Hänel

    Original Article – Clinical Oncology 28 September 2019 Pages: 3067 - 3073

    

17. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression

    • Maria-Alexandra Papadimitriou
    • Margaritis Avgeris
    • Andreas Scorilas

    Original Article – Clinical Oncology 08 October 2019 Pages: 3075 - 3087

    

18. The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

    • Cai Xiu
    • Xiao Li
    • Chunkang Chang

    Original Article – Clinical Oncology 26 September 2019 Pages: 3089 - 3097

    

19. Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancer

    • Andy Wang
    • Takefumi Komiya

    Original Article – Clinical Oncology 23 September 2019 Pages: 3099 - 3104

    

20. Tumor-infiltrating lymphocytes and CD8⁺ T cells predict survival of triple-negative breast cancer

    • H. Vihervuori
    • T. A. Autere
    • P. Kronqvist

    Original Article – Clinical Oncology Open access 27 September 2019 Pages: 3105 - 3114

    

21. The effectiveness of Wilms tumor screening in Beckwith–Wiedemann spectrum

    • Alessandro Mussa
    • Kelly A. Duffy
    • Jennifer M. Kalish

    Original Article – Clinical Oncology 04 October 2019 Pages: 3115 - 3123

    

22. “Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”

    • Neval E. Wareham
    • Qiuju Li
    • Jens D. Lundgren

    Original Article – Clinical Oncology 05 November 2019 Pages: 3125 - 3135

    

23. Reviewer Acknowledgements 2019

    ACKNOWLEDGEMENT TO REVIEWERS 12 November 2019 Pages: 3137 - 3139